Rchr
J-GLOBAL ID：202201000291380752
Update date: Jun. 17, 2024
Shimazu Yutaka
シマヅ ユタカ | Shimazu Yutaka
Affiliation and department：
Job title：
Doctor
Research theme for competitive and other funds (1)：
- 2022 - 2025 COVID-19における赤血球結合抗体産生病態解明と細胞外小胞を応用した病態制御
Papers (59)：
-
Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, et al. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients. Cancer Immunology, Immunotherapy. 2024
-
Yutaka Shimazu, Junya Kanda, Kazuhito Suzuki, Akinori Wada, Taku Kikuchi, Takashi Ikeda, Nobuhiro Tsukada, Akiyoshi Miwa, Mitsuhiro Itagaki, Shinichi Kako, et al. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation. Cancer Science. 2024
-
Kazuki Sakatoku, Makoto Murata, Yutaka Shimazu, Naoyuki Uchida, Satoshi Yoshihara, Yasufumi Uehara, Satoshi Takahashi, Hikaru Kobayashi, Haruyuki Tanaka, Nobuaki Nakano, et al. Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis. Bone Marrow Transplantation. 2024
-
Shuhei Kurosawa, Yoshimitsu Shimomura, Ken Ishiyama, Kyoko Fuse, Yutaka Shimazu, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Satoshi Takahashi, Masatoshi Sakurai, et al. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study. Bone marrow transplantation. 2024
-
Yutaka Shimazu. Acquired Factor V Inhibitor Developed after Radio-chemotherapy for Non-small Cell Lung Carcinoma. Oncology Advances. 2024
ｍore...
MISC (51)：
-
天ヶ瀬 寛記, 錦織 桃子, 秋山 大介, 赤荻 杏奈, 島津 裕, 近藤 忠一, 山下 浩平, 高折 晃史. 肺腺がんを合併した小リンパ球性リンパ腫の3例. 臨床血液. 2022. 63. 2. 146-146
-
宮下 明大, 上辻 由里, 中山 藍, 小森 友紀子, 山口 順子, 堤 康彦, 佐々木 奈々, 小林 裕, 島津 裕, 諫田 淳也, et al. A successfully managed refractory DLBCL case with CAR-T therapy and subsequent allo-SCT(和訳中). 日本血液学会学術集会. 2021. 83回. PS-7
-
高桑 輝人, 岡村 浩史, 島津 裕, 金子 仁臣, 今田 和典, 伊藤 量基, 山村 亮介, 太田 健介, 小杉 智, 田中 宏和, et al. Novel web application predicting patient-specific prognosis in MM from KMF using machine learning(和訳中). 日本血液学会学術集会. 2021. 83回. OS1-2
-
水野 昌平, 高見 昭良, 花村 一朗, 河村 浩二, 島津 裕, 半下石 明, 塚田 信弘, 賀古 真一, 菊池 拓, 太田 秀一, et al. Autologous hematopoietic cell transplantation in multiple myeloma patients infected with HBV or HCV(和訳中). 日本血液学会学術集会. 2021. 83回. OS1-3
-
淵田 真一, 伊藤 量基, 小杉 智, 太田 健介, 内山 人二, 島津 裕, 恩田 佳幸, 金子 仁臣, 足立 陽子, 高桑 輝人, et al. Efficacy of elotuzumab plus lenalidomide and dexamethasone for MM: A retrospective analysis from KMF(和訳中). 日本血液学会学術集会. 2021. 83回. OS1-4
ｍore...
Return to Previous Page
